![]() A fee is payable to the MHRA ( see fees section of the MHRA website).ĭetailed information on how to submit the application is available on the MHRA Applying to Conduct a Clinical Trial webpages. Trials with EU sites must be registered on the European Clinical Trials Database by obtaining a EudraCT number ( see station). In the UK, a Clinical Trial Authorisation (CTA) from Medicine and Healthcare Products Regulatory Agency (MHRA) is required for a Clinical Trial of an Investigational Medicinal Product (CTIMP). CTA Submission is a legal requirement for trials within the Clinical Trial Regulations scope. This station is part of the ‘trial approvals phase’ group of stations. ![]() ![]() The process occurs in parallel with Ethics Submission and R&D Submission. CTA Submission follows the IRAS station and precedes the Ethics Submission station.
0 Comments
Leave a Reply. |